{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02736",
      "entity_text" : "BBN receptor",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02740",
      "entity_text" : "ATBBN",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Solid-phase peptide syntheses of BBN receptor antagonists ATBBN (D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHCH 2 CH 3) and MATBBN (Gly-Gly-Gly-Arg-Asp-Asn-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHCH 2 CH 3), and agonists AGBBN (Aca-Gln-Trp-Ala-Val-Gly-His-Leu-MetNH 2) and MAGBBN (Gly-Gly-Gly-Arg-Asp-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-MetNH 2) were performed using standard Fmoc chemistry.",
  "reading_complete" : "2020-08-03T12:02:16Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:01:18Z",
  "trigger" : "antagonists",
  "evidence" : [ "BBN receptor antagonists ATBBN" ],
  "pmc_id" : "3086613",
  "score" : 0
}